Overview
Tesamorelin is a stabilised analogue of growth hormone releasing hormone (GHRH), modified to resist enzymatic degradation while retaining full GHRH receptor binding activity. This stability makes it a particularly useful research tool for studying pituitary GH secretion mechanisms and downstream IGF-1 signalling over extended experimental timeframes.
Nova Biolabs supplies Tesamorelin 10mg in lyophilised form from UK domestic stock, HPLC-verified at >98% purity.
Key Research Areas
GHRH Receptor Studies
Tesamorelin's full GHRH receptor agonism alongside its improved stability profile makes it a preferred tool for studying GHRH receptor activation and pituitary somatotroph function.
GH/IGF-1 Axis Research
Stimulation of GH release via the GHRH pathway makes Tesamorelin valuable for studying the downstream GH/IGF-1 signalling axis in hepatic and peripheral tissue models.
Visceral Adipose Tissue Research
Tesamorelin has been studied in research models examining the relationship between GH pulsatility and visceral adipose tissue metabolism.
Stability and Half-Life Studies
The compound's improved enzymatic stability compared to native GHRH makes it useful for pharmacokinetic and stability research in peptide science.
Product Specifications
| Format | Lyophilised powder |
| Quantity | 10mg per vial |
| Purity | >98% (HPLC verified) |
| Storage | Refrigerate at 2–8°C. Stable 24 months lyophilised. |
| Origin | UK domestic stock |
| Research use | In vitro / laboratory use only |